Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience-Reference-Cited by-同舟云学术

Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience

Published:2020-06-23 Issue:9 Volume:14 Page:2176-2189
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Klaassen Remy¹²^ORCID,Steins Anne¹²^ORCID,Gurney‐Champion Oliver J.³⁴,Bijlsma Maarten F.²⁵,Tienhoven Geertjan⁴,Engelbrecht Marc R. W.³,Eijck Casper H. J.⁶,Suker Mustafa⁶,Wilmink Johanna W.¹,Besselink Marc G.⁷,Busch Olivier R.⁷,Boer Onno J.⁸,Vijver Marc J.⁸,Hooijer Gerrit K. J.⁸,Verheij Joanne⁸,Stoker Jaap³,Nederveen Aart J.³,Laarhoven Hanneke W. M.¹^ORCID

Affiliation:

1. Department of Medical Oncology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

2. Laboratory for Experimental Oncology and Radiobiology Center for Experimental and Molecular Medicine Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

3. Department of Radiology & Nuclear Medicine Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

4. Department of Radiation Oncology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

5. Oncode Institute Amsterdam The Netherlands

6. Department of Surgery Erasmus Medical Center Rotterdam The Netherlands

7. Department of Surgery Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

8. Department of Pathology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam The Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12688

Reference41 articles.

1. Genomic analyses identify molecular subtypes of pancreatic cancer

2. Tumoral and Nontumoral Pancreas: Correlation between Quantitative Dynamic Contrast-enhanced MR Imaging and Histopathologic Parameters

3. Automated Selection of DAB-labeled Tissue for Immunohistochemical Quantification

4. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

5. Final analysis of a phase IB/randomized phase II study of gemcitabine (G) plus placebo (P) or vismodegib (V), a hedgehog (Hh) pathway inhibitor, in patients (pts) with metastatic pancreatic cancer (PC): A University of Chicago phase II consortium study.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerating MRI Uncertainty Estimation with Mask-Based Bayesian Neural Network;2024 IEEE 35th International Conference on Application-specific Systems, Architectures and Processors (ASAP);2024-07-24

2. Optimizing pseudo‐spiral sampling for abdominal DCE MRI using a digital anthropomorphic phantom;Magnetic Resonance in Medicine;2024-07-14

3. Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats;Cancers;2024-04-17

4. Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing;Frontiers in Oncology;2024-03-08

5. Intrapancreatic fat deposition is unrelated to liver steatosis in metabolic dysfunction-associated steatotic liver disease;JHEP Reports;2024-03